Nutreco
- Consolidated income statement
- Consolidated statement of comprehensive income
- Consolidated balance sheet
- Statement of changes in equity
- Consolidated cash flow statement
- Notes to the consolidated financial statements
- (1) Accounting policies used for the consolidated financial statements of Nutreco Holding N.V.
- (2) Reconciliation consolidated income statement
- (3) Operating segments
- (4) Discontinued operations and divestments
- (5) Assets and liabilities held for sale
- (6) Acquisitions
- (7) Other operating income
- (8) Personnel costs
- (9) Other operating expenses
- (10) Net financing costs
- (11) Income tax expense
- (12) Earnings per share
- (13) Property, plant and equipment
- (14) Intangible assets
- (15) Investments in associates
- (16) Other investments
- (17) Deferred tax assets and liabilities
- (18) Inventories
- (19) Biological assets
- (20) Trade and other receivables
- (21) Cash and cash equivalents
- (22) Equity attributable to the equity holders of the parent
- (23) Interest-bearing borrowings
- (24) Employee benefits
- (25) Provisions
- (26) Trade and other payables
- (27) Financial instruments and risk management
- (28) Contingent assets and liabilities
- (29) Related party transactions
- (30) Subsequent events
- (31) Accounting estimates and judgements
- (32) Notes to the consolidated cash flow statement
(32) Notes to the consolidated cash flow statement
General
The consolidated cash flow statement is drawn up on the basis of a comparison of the balance sheets as at 1 January and 31 December. Changes that do not involve cash flows, such as effects of movement in foreign exchange rates, revaluations and transfers to other balance sheet items, are eliminated. Changes in working capital due to the acquisition or sale of consolidated companies are included under investing activities.
Net cash from operating activities
Cash used for the payment of interest and income taxes reflects the actual amounts paid during the year.
Net cash used in investing activities
Cash used in the purchase of long-lived assets consists of the actual amounts paid during the year.
Dividends paid
In 2009 EUR 28.6 million (2008: EUR 32.0 million) dividend was paid to the shareholders of Nutreco on normal shares.
Sundry
Most of the movements in the cash flow statement can be reconciled to the movement schedules for the balance sheet items concerned. For those balance sheet items for which no detailed movement schedule is included, the table below shows the relation between the changes according to the balance sheet and the changes according to the cash flow statement:
|
(EUR x million) |
Working capital¹ |
Employee benefits |
Provisions |
Interest-bearing debt² |
|
As at year-end 2008 |
253.8 |
-38.6 |
-12.2 |
-518.9 |
|
As at year-end 2009 |
135.7 |
-53.7 |
-18.2 |
-423.9 |
|
Balance sheet movement |
118.1 |
15.1 |
6.0 |
-95.0 |
|
Adjustments |
||||
|
Effect of movement in foreign exchange |
4.7 |
-1.2 |
-0.1 |
-9.9 |
|
Acquisitions/divestments |
5.1 |
-2.0 |
- |
- |
|
Other |
-29.5 |
-2.3 |
- |
-0.6 |
|
Change in cash flow |
98.4 |
9.6 |
6.1 |
-105.5³ |
1 Inventories, biological assets, trade and other receivables, financial assets and trade and other payables.
2 Non-current interest-bearing borrowings and current interest-bearing borrowings excluding bank overdrafts.
3 Change in cash flow interest-bearing debt consists of repayment of borrowings of EUR -279.2 million and proceeds from borrowings EUR 173.8 million.
The adjustment “Other” for Working capital mainly comprises movements in the fair value of foreign exchange derivatives and the fair value of commodity derivatives which are presented in different categories in the cash flow statement.